Hongfeng Gou

12PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markersSolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 03, 2026
Megestrol acetate versus dexamethasone to prevent nausea and vomiting in patients with gastric or gastro-oesophageal junction cancer treated with oxaliplatin-based chemotherapy: study protocol of a multicentre, randomised, non-inferiority trial.

Haiyan Luo, Qiancheng Hu, Lianli Zeng

|Dec 01, 2025
Nab-paclitaxel-based chemotherapy with or without anti-PD-(L)1 immunotherapy as a second-line treatment for advanced biliary tract cancer: a real-world retrospective study.

Nan Zhou, Xinyi Li, Mingyou Gao

|Apr 29, 2025
Gastrointestinal tumor personalized immunotherapy: an integrated analysis from molecular genetics to imaging biomarkers.

Jian Guan, Xiaoling Gong, Hanjiang Zeng

|Jan 29, 2025
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer.

Sirui Tan, Mingyang Feng, Nan Zhou

|Jan 15, 2025
Impact of <sup>68</sup>Ga-FAPI positron emission tomography/computed tomography on staging and tumor management in patients with gastric cancer.

Shunyu Zhang, Minggang Su, Qianrui Li

|Dec 04, 2024
Chemotherapy combined with cadonilimab (AK104) as neoadjuvant treatment for locally advanced gastric/gastro-oesophageal junction adenocarcinoma: study protocol for a single-arm, phase II clinical trial.

Peng-Fei Zhang, Wei-Han Zhang, Xi-Jiao Liu

Pageof 2

Frequent Collaborators

3 joint publications

Cheng Yi

1 joint publications

Peng-Fei Zhang

1 joint publications

Wei-Han Zhang

1 joint publications

Kun Yang